Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Securities and Exchange Commission v. One Or More Unknown Traders In The Securities Of Onyx Pharmaceuticals, Inc.
Case Number:
1:13-cv-04645
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
September 16, 2015
UAE Investors Dodge SEC's $3.7M Insider Trading Suit
Two investors from the United Arab Emirates scored a victory on Tuesday when the U.S. Securities and Exchange Commission agreed to drop a $3.7 million suit in New York federal court accusing them of insider trading in a pharmaceutical company's stock.
-
June 09, 2015
Newman Can't Save Investors In SEC Insider Trading Case
A New York federal judge Monday refused to toss an insider trading case brought by the U.S. Securities and Exchange Commission against two United Arab Emirates investors, saying the Second Circuit's Newman decision does not alter the standard for pleading a "plausible" insider trading claim.
-
December 19, 2014
Onyx Traders Say Newman Undermines SEC Insider Case
In the latest fallout from the Second Circuit's decision in U.S. v. Newman, two Dubai investors claim they can't be sued by the U.S. Securities and Exchange Commission over an alleged $3.7 million insider trading scheme involving Onyx Pharmaceuticals Inc. stock because they didn't know about benefits given to the alleged tipster.
-
November 06, 2014
SEC May Question Journalist In Onyx Insider Trading Probe
The U.S. Securities and Exchange Commission said Thursday it may seek to depose a journalist at the Financial Post in Canada who reported a possible $10 billion takeover of Onyx Pharmaceuticals Inc. in 2013, as the agency investigates alleged insider trades in Onyx stock around the same time.
-
September 29, 2014
Onyx Traders Can't Kill SEC's $4M Insider Trading Suit
A New York federal judge on Monday refused to toss a U.S. Securities and Exchange Commission suit alleging two United Arab Emirates investors reaped $3.7 million through insider trading in Onyx Pharmaceuticals Inc. and Life Technologies Corp., finding it sufficiently states a claim.